These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

735 related articles for article (PubMed ID: 29620054)

  • 1. Haemochromatosis.
    Brissot P; Pietrangelo A; Adams PC; de Graaff B; McLaren CE; Loréal O
    Nat Rev Dis Primers; 2018 Apr; 4():18016. PubMed ID: 29620054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel SLC40A1 p.Y333H mutation with gain of function of ferroportin: A recurrent cause of haemochromatosis in China.
    Zhang W; Xu A; Li Y; Zhao S; Zhou D; Wu L; Zhang B; Zhao X; Wang Y; Wang X; Duan W; Wang Q; Nan Y; You H; Jia J; Ou X; Huang J;
    Liver Int; 2019 Jun; 39(6):1120-1127. PubMed ID: 30500107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary hemochromatosis: mutations in genes involved in iron homeostasis in Brazilian patients.
    Santos PC; Cançado RD; Pereira AC; Schettert IT; Soares RA; Pagliusi RA; Hirata RD; Hirata MH; Teixeira AC; Figueiredo MS; Chiattone CS; Krieger JE; Guerra-Shinohara EM
    Blood Cells Mol Dis; 2011 Apr; 46(4):302-7. PubMed ID: 21411349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanisms of systemic iron homeostasis and etiology, diagnosis, and treatment of hereditary hemochromatosis.
    Kawabata H
    Int J Hematol; 2018 Jan; 107(1):31-43. PubMed ID: 29134618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HFE, hepcidin and ferroportin gene mutations are not present in Indian patients with primary haemochromatosis.
    Shukla P; Julka S; Bhatia E; Shah S; Nagral A; Aggarwal R
    Natl Med J India; 2006; 19(1):20-3. PubMed ID: 16570681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term phlebotomy successfully alleviated hepatic iron accumulation in a ferroportin disease patient with a mutation in SLC40A1: a case report.
    Nishina S; Tomiyama Y; Ikuta K; Tatsumi Y; Toki Y; Kato A; Kato K; Yoshioka N; Sasaki K; Hara Y; Hino K
    BMC Gastroenterol; 2021 Mar; 21(1):111. PubMed ID: 33673803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment.
    Pietrangelo A
    Gastroenterology; 2010 Aug; 139(2):393-408, 408.e1-2. PubMed ID: 20542038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into the regulation of iron homeostasis.
    Deicher R; Hörl WH
    Eur J Clin Invest; 2006 May; 36(5):301-9. PubMed ID: 16634833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective release of Hepcidin not defective synthesis is the primary pathogenic mechanism in HFE-Haemochromatosis.
    Arnold J; Sangwaiya A; Bhatkal B; Arnold A
    Med Hypotheses; 2008; 70(6):1197-200. PubMed ID: 18054440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherited Disorders of Iron Overload.
    Pantopoulos K
    Front Nutr; 2018; 5():103. PubMed ID: 30420953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-HFE-related hereditary iron overload].
    Aguilar-Martinez P
    Presse Med; 2007 Sep; 36(9 Pt 2):1279-91. PubMed ID: 17540536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular genetics of haemochromatosis.
    Le Gac G; Férec C
    Eur J Hum Genet; 2005 Nov; 13(11):1172-85. PubMed ID: 16132052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic expression of hemochromatosis genes in two mouse strains after phlebotomy and iron overload.
    Bondi A; Valentino P; Daraio F; Porporato P; Gramaglia E; Carturan S; Gottardi E; Camaschella C; Roetto A
    Haematologica; 2005 Sep; 90(9):1161-7. PubMed ID: 16154838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress in iron metabolism research].
    Kawabata H
    Rinsho Ketsueki; 2017; 58(10):1864-1871. PubMed ID: 28978826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-HFE haemochromatosis.
    Wallace DF; Subramaniam VN
    World J Gastroenterol; 2007 Sep; 13(35):4690-8. PubMed ID: 17729390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-
    Lv T; Zhang W; Xu A; Li Y; Zhou D; Zhang B; Li X; Zhao X; Wang Y; Wang X; Duan W; Wang Q; Xu H; Zheng J; Zhao R; Zhu L; Dong Y; Lu L; Chen Y; Long J; Zheng S; Wang W; You H; Jia J; Ou X; Huang J
    J Med Genet; 2018 Oct; 55(10):650-660. PubMed ID: 30166352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis.
    Bridle KR; Frazer DM; Wilkins SJ; Dixon JL; Purdie DM; Crawford DH; Subramaniam VN; Powell LW; Anderson GJ; Ramm GA
    Lancet; 2003 Feb; 361(9358):669-73. PubMed ID: 12606179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare types of genetic hemochromatosis.
    Camaschella C; Poggiali E
    Acta Haematol; 2009; 122(2-3):140-5. PubMed ID: 19907151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular basis in hereditary haemochromatosis].
    Cadet E; Perez AS; Capron D; Rochette J
    Rev Med Interne; 2005 May; 26(5):393-402. PubMed ID: 15893030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-HFE hemochromatosis: genetics, pathogenesis, and clinical management.
    Nelson JE; Kowdley KV
    Curr Gastroenterol Rep; 2005 Feb; 7(1):71-80. PubMed ID: 15701302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.